These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12786828)

  • 1. Reduced expression of actin-binding proteins, h-caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma.
    Koganehira Y; Takeoka M; Ehara T; Sasaki K; Murata H; Saida T; Taniguchi S
    Br J Dermatol; 2003 May; 148(5):971-80. PubMed ID: 12786828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
    Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
    Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin.
    Frid MG; Shekhonin BV; Koteliansky VE; Glukhova MA
    Dev Biol; 1992 Oct; 153(2):185-93. PubMed ID: 1397676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
    Liegl B; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
    Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
    Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.
    Nürnberg W; Tobias D; Otto F; Henz BM; Schadendorf D
    J Pathol; 1999 Dec; 189(4):546-51. PubMed ID: 10629556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
    Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
    Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development.
    Duband JL; Gimona M; Scatena M; Sartore S; Small JV
    Differentiation; 1993 Dec; 55(1):1-11. PubMed ID: 8299876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
    Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
    J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas].
    Li ZW; Wang Y; Xue WC; Si L; Cui CL; Cao DF; Zhou LX; Guo J; Lu AP
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):801-5. PubMed ID: 24507096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
    Bayer-Garner IB; Hough AJ; Smoller BR
    Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
    Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.